CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Charych Deborah H. Director | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2025-02-24 | Diep Tuan Tu Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2025-02-24 | Arora Puneet S. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +38,000 | 38,000 | ||
| 2024-11-18 | ARSENAULT KAITLYN Chief Financial Officer | Sale | −43,026 | $4.99 | $215K | 167,522 |
| 2024-11-18 | Diep Tuan Tu Chief Development Officer | Sale | −19,489 | $4.99 | $97K | 82,259 |
| 2024-11-18 | ARSENAULT KAITLYN Chief Financial Officer | Sale | −43,206 | $4.99 | $216K | 166,342 |
| 2024-11-18 | DHILLON PUNIT Chief Executive Officer | Sale | −82,546 | $4.99 | $412K | 329,823 |
| 2024-11-18 | Grayson Paul A. Director | Sale | −86,244 | $4.99 | $430K | 259,701 |
| 2024-11-15 | ARSENAULT KAITLYN Chief Financial Officer | Sale | −190 | $5.55 | $1K | 210,548 |
| 2024-11-15 | Diep Tuan Tu Chief Development Officer | Sale | −85 | $5.55 | $472 | 101,748 |
| 2024-11-15 | ARSENAULT KAITLYN Chief Financial Officer | Sale | −190 | $5.55 | $1K | 209,548 |
| 2024-11-15 | DHILLON PUNIT Chief Executive Officer | Sale | −364 | $5.55 | $2K | 412,369 |
| 2024-11-15 | Grayson Paul A. Director | Sale | −307 | $5.55 | $2K | 345,945 |
| 2024-10-28 | Diep Tuan Tu Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-10-28 | ARSENAULT KAITLYN Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-10-28 | DHILLON PUNIT Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +650,000 | 650,000 | ||
| 2024-10-28 | Schwab Andrew J. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-10-28 | Grayson Paul A. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-10-28 | Smith Karen L. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2024-10-28 | Charych Deborah H. Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 |
Page 6 of 15 · 292 trades